"Designing Growth Strategies is in our DNA"

Lung Cancer Surgery Market Size, Share & Industry Analysis, By Procedure Type (Lobectomy, Segmentectomy, Pneumonectomy, and Others), By Surgical Approach (Open Surgery, Video-Assisted Thoracoscopic Surgery (VATS), and Robotic-Assisted Thoracic Surgery (RATS)), By Cancer Type (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), By Provider (Hospitals, Cancer Care Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI115411

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 3.0% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Procedure Type, Surgical Approach, Cancer Type, Provider, and Region

By Procedure Type

·         Lobectomy

·         Segmentectomy

·         Pneumonectomy

·         Others

By Surgical Approach

·         Open Surgery

·         Video-Assisted Thoracoscopic Surgery (VATS)

·         Robotic-Assisted Thoracic Surgery (RATS)

By Cancer Type

·         Non–Small Cell Lung Cancer (NSCLC)

·         Small Cell Lung Cancer (SCLC)

By Provider

·         Hospitals

·         Cancer Care Centers

·         Others

By Region

·         North America (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country)

o   U.S. (By Cancer Type)

o   Canada (By Cancer Type)

·         Europe (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region)

o   U.K. (By Cancer Type)

o   Germany (By Cancer Type)

o   France (By Cancer Type)

o   Italy (By Cancer Type)

o   Spain (By Cancer Type)

o   Scandinavia (By Cancer Type)

o   Rest of Europe (By Cancer Type)

·         Asia Pacific (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region)

o   China (By Cancer Type)

o   Japan (By Cancer Type)

o   India (By Cancer Type)

o   Australia (By Cancer Type)

o   Southeast Asia (By Cancer Type)

o   Rest of Asia Pacific (By Cancer Type)

·         Latin America (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region)

o   Brazil (By Cancer Type)

o   Mexico (By Cancer Type)

o   Rest of Latin America (By Cancer Type)

·         Middle East & Africa (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region)

o   GCC (By Cancer Type)

o   South Africa (By Cancer Type)

o   Rest of the Middle East & Africa (By Cancer Type)

  • 2021-2034
  • 2025
  • 2021-2024
  • 261
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports